Molecular and clinical heterogeneity in pyruvate kinase deficiency in India

被引:31
|
作者
Warang, Prashant [1 ]
Kedar, Prabhakar [1 ]
Ghosh, Kanjaksha [1 ]
Colah, Roshan [1 ]
机构
[1] Indian Council Med Res, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
Pyruvate kinase; Hemolytic anemia; Red cell enzymes; Molecular modeling; Glycolytic enzymes; PK-LR GENE; MUTATIONS; IDENTIFICATION; ISOZYMES;
D O I
10.1016/j.bcmd.2013.05.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the PK-LR gene in 10 unrelated Indian patients with congenital haemolytic anemia associated with erythrocyte pyruvate kinase deficiency. The patients had a variable presentation ranging from a very mild compensated hemolysis to severe anemia. Nine different mutations were detected among the 20 mutated alleles identified: one deletion (c.1042-1044del) p.Lys348del and eight single-nucleotide (nt) substitutions resulting in amino acid exchanges c.397A>G (p.Asn133Asp), c.992A>G (p.Asp331Gly), c.1072G>A (p.Gly358Arg), c.1076G>A (p.Arg359His), c.1219G>A (p.Glu407Lys), c.1241C>T (p.Pro414Leu), c.1436G>A (p.Arg479His) and c.1529G>A (p.Arg510Gln) were identified. Although all the exons, the flanking regions and the promoter region were sequenced in all cases, we failed to detect the second expected mutation in two subjects. Two mutations [c.397A>G; c.1241C>T] were novel. These novel missense mutations involved highly conserved amino acids. Two mutations were identified for the first time in the homozygous state globally (c1042-1044del; c.1072G>A) and two other mutations were identified for the first time in our population (c.1076G>A; c.1529G>A). This study along with our earlier report suggests that the most frequent mutations in India would appear to be c.1436G>A (18.33%), followed by c.992A>G (11.66%) and c.1456C>T (11.66%). Structural implications of amino acid substitutions were correlated with the clinical phenotypes seen. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 50 条
  • [31] Deferasirox in pyruvate kinase deficiency
    Dries Deeren
    Annals of Hematology, 2009, 88 : 397 - 397
  • [32] PYRUVATE-KINASE DEFICIENCY
    MIWA, S
    FUJII, H
    CLINICAL BIOCHEMISTRY, 1990, 23 (02) : 155 - 157
  • [33] Pyruvate kinase deficiency in children
    Chonat, Satheesh
    Eber, Stefan W.
    Holzhauer, Susanne
    Kollmar, Nina
    Morton, D. Holmes
    Glader, Bertil
    Neufeld, Ellis J.
    Yaish, Hassan M.
    Rothman, Jennifer A.
    Sharma, Mukta
    Ravindranath, Yaddanapudi
    Wang, Heng
    Breakey, Vicky R.
    Sheth, Sujit
    Bradeen, Heather A.
    Al-Sayegh, Hasan
    London, Wendy B.
    Grace, Rachael F.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [34] PYRUVATE-KINASE DEFICIENCY
    MIWA, S
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1445 - 1452
  • [35] Diagnosis of Pyruvate Kinase Deficiency
    Gallagher, Patrick G.
    Glader, Bertil
    PEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 771 - 772
  • [36] Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency
    Bianchi, Paola
    Fermo, Elisa
    Glader, Bertil
    Kanno, Hitoshi
    Agarwal, Archana
    Barcellini, Wilma
    Eber, Stefan
    Hoyer, James D.
    Kuter, David J.
    Maia, Tabita Magalhaes
    Manu-Pereira, Maria del Mar
    Kalfa, Theodosia A.
    Pissard, Serge
    Segovia, Jose-Carlos
    van Beers, Eduard
    Gallagher, Patrick G.
    Rees, David C.
    van Wijk, Richard
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : 149 - 161
  • [37] PYRUVATE-KINASE DEFICIENCY .1. CLINICAL AND HEMATOLOGICAL OBSERVATIONS
    SCHROTER, W
    WONNEBERGER, B
    MONATSSCHRIFT KINDERHEILKUNDE, 1976, 124 (01) : 1 - 8
  • [38] Red cell pyruvate kinase deficiency: from genetics to clinical manifestations
    Zanella, A
    Bianchi, P
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2000, 13 (01) : 57 - 81
  • [39] MOLECULAR-GENETIC HETEROGENEITY OF PHOSPHOGLYCERATE KINASE (PGK) DEFICIENCY
    TSUJINO, S
    SHANSKE, S
    DIMAURO, S
    MUSCLE & NERVE, 1995, : S45 - S49
  • [40] Validation of the Pyruvate Kinase Deficiency Diary (PKDD): A PatientReported Outcome Measure for Pyruvate Kinase (PK) Deficiency
    Egan, Shayna
    Zagadailov, Erin
    Jewett, Adrian
    Li, Junlong
    Tai, Feng
    Boscoe, Audra
    Andrae, David A.
    BLOOD, 2021, 138